chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dysautonomia; permanently mentally disabled; permanently physically disabled; sick; Initial information received on 23-Nov-2020 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional via social media.  This case involves patient (unknown demographics) who experienced dysautonomia (autonomic nervous system imbalance), permanently mentally disabled (mental disability), permanently physically disabled (physical disability), sick (illness) when received INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious dysautonomia (autonomic nervous system imbalance) 2-months following the administration of INFLUENZA VACCINE.   On an unknown date, the patient developed a serious permanently mentally disabled (mental disability), permanently physically disabled (physical disability), sick (illness) unknown latency following the administration of INFLUENZA VACCINE.   These events were leading to disability.  Laboratory details were not reported.   It was not reported if the patient received a corrective treatment.  At the time of this report, outcome of the events were not recovered (now permanently physically and mentally disabled).   Information on the batch number was requested.; Sender's Comments: This poorly documented social media case concerns a patient (unknown demographics) who suffered from autonomic nervous system imbalance, mental disability, physical disability and illness after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset was compatible. However, patient's medical condition at the time of vaccination, lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.
General Body aches started 6pm on 9/10/21  lasted till 9/11/21. noted first red rash on right abdomen on 9/11 & second rash on 9/14/21 with itching but no pain. I still have 2 small rashes & somewhat fading away. rashes looks like shingles rash.
Patient was scheduled and administered COVID-19 Moderna on 4/19/2021. At the time we were not aware that she had previously been vaccinated at another facility for both vaccines in the series. She received moderna vaccinations on 2/24/2021 and 3/24/2021 administered by CVS pharmacy at the assisted living facility that she resides. Patient has dementia and didn't recall having the vaccine prior to 4/19/2021 appointment.  Does not have any side effects or symptoms at this time.
Got the vaccine, the arm in which she received the vaccine became very swollen, and hard, and very deep red in color from the injection site all the way down to about 3" above the elbow.  It's very hot to touch.  She has been keeping ice on it and taking Tylenol for the pain.  She is not getting any sleep due to the arm pain all night, and it's not just the tenderness but has burning shooting/sharp pain and an ache for a very short amount of time that feels like it's coming from the inside.   It aches and comes and aches for a few seconds, and then goes away.  The reaction to the arm that does not go away is that it feels like she has burned it.   She did not call her doctor but did talk to her pharmacist who told her to call and report the reaction.  She also has run a low grade fever and not feeling very good.
Pt recv vax on 4/7/99; on 4/8/99 pt exp local rxn of redness/ swelling on rt thigh, thigh had "doughy" feel w/ blanched vax site, fever (99.8); tx=Tylenol & Benadryl
I got the first COVID vaccine on March 8th. The next day, I  had a rash on my chest and thighs that became hives. The hives were hot and itchy. This reaction gradually grew worse and the rash spread to the rest of my legs, down my arms, and to my belly.  When it started up my neck, I noticed that my throat was getting a bit sore and tight. I called my primary care provider and she told me to go to the ER.  The ER providers drew blood, which was normal except for low potassium and elevated red blood cells. They treated me with IV Benadryl and steroids, which caused the symptoms to dissipate quickly. The doctor also prescribed Pepcid and an epipen.
Information has been received from a physician concerning an otherwise healthy 12 year old male with no allergies or history of chickenpox who in August 1999 was vaccinated with a dose of varicella virus vaccine live. There was no concomitant therapy. The physician reported that in approximately October 2003, the pt developed extensive severe herpes zoster in one dermatome in which an isolate grew varicella zoster virus (VZV). Unspecified medical attention was sought. It was noted that the pt had not had a recent exposure to chickenpox. On 10/28/03, a vesicle lesion was obtained and sent to the lab for analysis. Subsequently recovered from the severe herpes zoster. Results from PCR testing revealed that the pt had wild-type VZV infection. The physician also reported that another pt had died from VZV infection after being possibly exposed to someone who had been vaccinated with varicella virus vaccine live (WAES # 0312USA01394).  No further information is available.
After a couple of days started feeling pain in the right elbow.  I thought it would go away.  It didn't. As of today pain is still there it is not as bad but still there 27 days later.  Also my left thumb is numb and sometimes radiates to the forearm area.  I have just started taking 200 mg ibuprofen as needed.  Helps with the right elbow but no relief to the left thumb.  I am due for 2nd vaccine tomorrow!
PULLING 0.5ML X 6 DOSES FROM ONE  VIAL, INSTEAD OF 5 DOSES; PULLING 0.5ML X 6 DOSES FROM ONE  VIAL, INSTEAD OF 5 DOSES; This spontaneous report received from a vaccine facility concerned patients of unspecified number, age and sex. The patient's weight, height, and medical history were not reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The lot number was not reported. The company was unable to perform follow up to request batch number. No concomitant medications were reported. On an unspecified date, the vaccine providers were pulling 0.5mL x 6 doses from one vial instead of the indicated of 5 doses from the vaccine vial. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pulling 0.5ml x 6 doses from one vial, instead of 5 doses was not reported. This report was non-serious.
This spontaneous report as received from a pharmacist refers to a 53 year old female patient with asthma. On 16-SEP-2013, the patient was vaccinated with PNEUMOVAX 23 lot number H009826, expiration date 11-FEB-2014 (dose, strength and route were not reported. On 24-SEP-2014, the patient was vaccinated with PNEUMOVAX23, 0.5 ml, intramuscular, lot number reported as K009809, expiration date 16-SEP-2015. Pharmacist reported that a patient received a dose of PNEUMOVAX 23 and then informed the pharmacist after she received a dose that she received a dose of PNEUMOVAX in 16-SEP-2013 (reported as "last year"). The patient had not experienced or demonstrated any adverse effects. Additional information has been requested.
urticarial rxn-hives started 7PM;DPH relieved, 11JAN in AM hives again pt to MD office
This spontaneous report as received from a Registered Nurse refers to a 15 year old male patient. On an unknown date the patient was vaccinated with PROQUAD (dose and lot # were unknown) subcutaneously. No adverse effect reported. Additional information has been requested.
This is a spontaneous report from a contactable other healthcare professional. A 24-month-old patient of an unspecified gender received the fourth dose PREVNAR 13; (lot number and expiration date were unknown), via an unspecified route of administration on 24Oct2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine 5 days ago (24Oct2018) and the patient experienced irritability and decreased ability to verbalize, and the child was squealing more than talking on an unspecified date in 2018. The reporter wanted to know if the events were due to the vaccine. The outcome of the events irritability and "ability to verbalize, and the child was squealing more than talking" was unknown. Information on the batch/lot number has been requested.
Headache, nausea, lightheadedness, dizziness, extreme fatigue, eventually fainted landed on my right side of my face and broke my orbit and cheek bone. Now have to go see facial surgeon. Also have cuts, bruises, aches and pains on entire right side of body. Cannot open jaws right now, going to have to miss work.
Swollen left deltoid above and below injection site.  1.5? by 6? in surface area and approximately 1/2? (a half inch) in elevation.
Patient had a vasovagal episode around 10 minutes at 1521 on 6/11/2021 after dose 1 of the Pfizer COVID vaccine. She never had syncope. Nurse had the patient lie down and elevate her legs. She reported the lightheadedness as resolving with the position change. Patient reported she had not eaten all day. Juice, water, and crackers were provided. HR, pulse ox, and BP monitoring initiated. Pt's HR ranged from 40-60BPM and was labile throughout the time she was observed until EMS transport. BP was cycled three times while awaiting EMS transport, the reading were 88/33, 133/78, and 155/87 listed in chronological order. Pulse ox ranged from 90-100% over the same time period. Clinic doctor recommended EMS transport to the ED for a 4-hour observation. EMS arrived and transported the patient to the Hospital Emergency Department.
COVID+ PTA, increasing SOB x6 days. Admit for COVID pna and resp failure. Fully vaccinated March 2021. O2, steroids, remdesivir, singulair, Baricitinib (d/c during therapy due to DVT). Escalated to vent 9/28 and developed renal failure. Transitioned to comfort care and passed away 10/17.
Severe headache, nausea, dizziness, fever and sore lymph nodes started less than 24 hours after 1st dose and have continued since. On day 7 at the time of reporting this and still having side effects
Swelling and redness of rt arm. Tx cold compress.  1 1/2 tsp. BENADRYL.
Sudden onset menorrhagia. Had a uterine ablation to lessen the bleeding in March 2022, but periods are still heavy.
Patient came in on 12/12/22 to report a large rash on arm spanning about 6-8 inches from vaccination sites. It was very red and patient said it lighten to lighter pink. Patient also states there were some rash underneath her breast as well. Upon discussion with patient, the rash is still very visible and large.
moderate localized erythema, warmth no tenseness of compartment. 5 inch diameter circle of erythema of midarm-2 days after administered-Tylenol and Motrin. mild axillary lymphadenopathy-nontender
2 years ago we started administering Shingrix to our employees, Some employees have not; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 29-Apr-2022 Reporter's Comments: The reporter was a health center manager for on onsite employee wellness center and were opening back up for employees to return to work soon. 2 years before reporting they started administering Shingrix to their employees then the center shut down. Some employees had not received 2nd dose. No additional data was available. Additional Supportive Information: The patients did not receive the 2nd dose of Shingrix till the time of reporting, which led to incomplete course of vaccination.
Chills/had chills all day/cold; Fever of 102; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills/had chills all day/cold) and PYREXIA (Fever of 102) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included Pneumonia. Concurrent medical conditions included Cancer. Concomitant products included LOSARTAN and AMLODIPINE for an unknown indication, HYDROCHLOROTHIAZIDE.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced CHILLS (Chills/had chills all day/cold) and PYREXIA (Fever of 102). At the time of the report, CHILLS (Chills/had chills all day/cold) and PYREXIA (Fever of 102) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Information has been received from a physician concerning a 13 year old male who on 08-FEB-1998 and 23-AUG-2000 was vaccinated with the first and second dose of MMR II (HSA) (LOT# not reported). On 09-NOV-2009 the patient experienced mumps. On 09-DEC-2009, the patient was diagnosed with mumps. The blood work was done on 10-DEC-2009 and the result was not reported. The patient's outcome was unknown, this case was non serious.  Follow-up information has been received concerning the male patient who on 17-NOV-2009 (previously reported as 09-NOV-2009) experienced onset of symptoms. On 19-NOV-2009 (previously reported as 09-DEC-2009), the patient was diagnosed with mumps. The patient was afebrile and had bilateral parotitis. On 19-NOV-2009, the blood work was done and revealed that IgM was negative, IgG was 2.11 and serum amylase was 53. At the time of the report, the patient's outcome was unknown. No further information is available.
flu like symptoms; CHILLS; MUSCLE ACHES; HEADACHE; fever of 100F - 101F; arm was sore; arm was sore  / extending down to the elbow; NERVE PAIN; not been able to sleep; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received on 6th September 2019, refer case US2020AMR058222).   On 20th February 2020, the patient received the 2nd dose of Shingrix. On 20th February 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, pain in elbow, nerve pain and sleeplessness. On 21st February 2020, the patient experienced influenza-like symptoms, chills, muscle pain, headache and fever. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms, chills, muscle pain, headache and fever were recovered/resolved and the outcome of the pain in arm, pain in elbow, nerve pain and sleeplessness were unknown.   It was unknown if the reporter considered the influenza-like symptoms, chills, muscle pain, headache, fever, pain in arm, pain in elbow, nerve pain and sleeplessness to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in right arm. The day after vaccination, the patient experienced influenza-like symptoms, chills, muscle pain, headache and fever. In the night of the vaccination, the patient's arm was sore and became more severe on Saturday night presenting in the upper arm and extending down to the elbow, the patient described it as nerve pain and was not been able to sleep since Saturday night due to pain in arm. The reporter consented to follow up.
Headache since shot. Nausea, chills, and fever. Redness, pain, swelling  around injection site
red & sore upper arm, indurated, redness, swelling @ site, warm @ site;
updated patient information; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (updated patient information) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (updated patient information). At the time of the report, EXPIRED PRODUCT ADMINISTERED (updated patient information) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were provided.      Reporter did not allow further contact
Profound lethargy - nausea & vomiting 30 hrs prior to hosp admission. temp 100.8, admitted 30JAN91.
Pt was seen falling forward out of chair to the floor with hands shaking . Patient did not remember what happened but stated that she has a history of seizures and fainting after injections. Patient received an ice pack for her lip and no other treatments. EMS was called and patient was taken to hospital.
left side weakness; muscle weakness; dizziness; arm site injection pain; nausea; chills; body ache; low grade fever; headache; vomiting; twitching; This spontaneous case was reported by a consumer and describes the occurrence of HEMIPARESIS (left side weakness) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040C21A and 039C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jul-2021, the patient experienced MUSCLE TWITCHING (twitching). On an unknown date, the patient experienced HEMIPARESIS (left side weakness) (seriousness criterion medically significant), MUSCULAR WEAKNESS (muscle weakness), DIZZINESS (dizziness), VACCINATION SITE PAIN (arm site injection pain), NAUSEA (nausea), CHILLS (chills), MYALGIA (body ache), PYREXIA (low grade fever), HEADACHE (headache) and VOMITING (vomiting). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Herpes simplex type II, at an unspecified dose and frequency; PHENTERMINE HYDROCHLORIDE (ADIPEX-P) for Weight loss, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEMIPARESIS (left side weakness), MUSCULAR WEAKNESS (muscle weakness), DIZZINESS (dizziness), MUSCLE TWITCHING (twitching), VACCINATION SITE PAIN (arm site injection pain), NAUSEA (nausea), CHILLS (chills), MYALGIA (body ache), PYREXIA (low grade fever), HEADACHE (headache) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: normal (normal) normal. In 2021, Computerised tomogram: normal (normal) normal. In 2021, Electrocardiogram: normal (normal) normal. In 2021, Laboratory test: normal (normal) normal.         Concomitant product was not provided.  Based on the current available information and temporal association between the use of the product and the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the events, a causal relationship cannot be excluded.
fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010m208) for COVID-19 vaccination.     No Medical History information was reported.    On 24-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown. Not Provided          no concomitant medications are reported. treatment to the events not provided. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: follow up information received on 25-may-2021 it does not contain any new information.
including any and all of it sequelae/as well as other severe and permanent health consequences; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently unknown gender elderly patient of 69year-old. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around unknown date in  2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot number, expiration date, dose, dose number, and route not specified) for long-term prevention of shingles and zoster-related conditions (prophylaxis). Shortly after vaccination, on or about June 2012, the patient suffered shingles. Subsequently, the patient was treated for the injury: shingles. As a direct and proximate result of his receipted of zoster vaccine live (ZOSTAVAX), the patient had suffer severe and permanent injuries, including but not limited to shingles, as well as other severe and permanent heath consequences. Also, had endured substantial pain and suffering, had incurred significant expenses for medical care and treatment, and will continue to incur such expenses in the future. Had suffered and will continue to suffer economic loss, and had otherwise been physically, emotionally, and economically injured. The patient injuries and damages were permanent and will continue in the future.The outcome of the event shingles and Ill-defined disorder was reported as not recovered.
Heart went into fast BPM and irregular rhythm on2/07/2021.   Stayed in Afib Until 02/18/2021 with spontaneous conversion.
This spontaneous report was received from a health care student refers to a 3 month old patient of unknown gender. No relevant medical history of the patient was reported. On 16-JUL-2014 the patient was vaccinated with PNEUMOVAX23 (strength, dose, route of administration, site of administration, lot number and expiration dates were not reported). There was no concomitant medications reported. It was reported that the patient received PNEUMOVAX23 instead of PREVNAR on 16-JUL-2014. There were no adverse symptoms reported. It was unspecified whether the patient had sought any medical attention. There was no product quality complaint involved. The outcome of received PNEUMOVAX23 instead of PREVNAR was unknown. Additional information has been requested.